UNSPSC 51111651: Pirazofurin or pyrazofurin

This classification denotes a pyrimidine antagonist and orotidylate decarboxylase inhibitor with the molecular formula C9H13N3O6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 4B15044GQZ, chemically known as 1h-pyrazole-5-carboxamide, 4-hydroxy-3-beta-d-ribofuranosyl- but generally known as pirazofurin, which bears US NIH Compound Identifier 5360877. European Medicines Agency schedules Pirazofurin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09897MIG.

UNSPSC 51111651 Pirazofurin or pyrazofurin, a Commodity code, identifies a specific antifungal pharmaceutical compound. The source provides no recent state or local procurement opportunities under this code, and no documentation of what state and local governments are actually purchasing in this category.

The code appears to address a narrowly specialized pharmaceutical ingredient or active pharmaceutical ingredient (API) rather than a finished medication or broad therapeutic class. Without recent solicitation data, no characterization is possible of the issuing-body mix, geographic spread, or representative opportunities that would signal current market activity or procurement intent in state and local government.